Skip to main content
. 2019 Mar 19;6(5):990–1005. doi: 10.1002/acn3.762

Figure 2.

Figure 2

Risk stratification of SHH‐activated medulloblastomas including prognostic biomarker candidates across all age groups as defined by Ramaswamy et al. (2016) (A), Schwalbe et al. (2017) (B) and Cavalli et al. (2017) (C).